PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.5% - What's Next? - MarketBeat12 hours ago • Google News
PRCT: Procedure growth, inventory right-sizing, and HYDROS upgrades drive future growth outlook - TradingView2 days ago • Google News
Morgan Stanley Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $51 - 富途牛牛2 days ago • Google News